Mesial temporal sclerosis--a late complication in four allogeneic pediatric recipients with persistent seizures after an acute episode of cyclosporine-A neurotoxicity

Bone Marrow Transplant. 2003 May;31(10):919-22. doi: 10.1038/sj.bmt.1704023.

Abstract

Mesial temporal sclerosis (MTS) is a common finding in patients with intractable temporal lobe epilepsy (TLE). In this report, we retrospectively reviewed the neuroimaging results of four children who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT), and who developed recurrent, partial, intractable seizures following a first event caused by cyclosporine-A (CSA) neurotoxicity. Neuroradiologic findings of MTS were demonstrated in all these patients. We suggest that MTS may be a consequence of CSA neurotoxicity, which induces repeated seizures, associated with other predisposing conditions, as well as being a consequence of the underlying disease and its treatment, and of severe graft-versus-host disease (GvHD).

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Child, Preschool
  • Cyclosporine / adverse effects*
  • Epilepsy, Temporal Lobe / etiology*
  • Epilepsy, Temporal Lobe / pathology
  • Histiocytosis, Non-Langerhans-Cell / therapy*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Infant
  • Male
  • Neurotoxins / adverse effects
  • Osteoporosis / therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Sclerosis
  • Seizures / etiology
  • Stem Cell Transplantation / adverse effects*
  • Transplantation Conditioning / adverse effects*

Substances

  • Immunosuppressive Agents
  • Neurotoxins
  • Cyclosporine